Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.

Expert opinion on drug metabolism & toxicology - 1 Aug 2014

Fabbri Chiara, Minarini Alessandro, Niitsu Tomihisa, Serretti Alessandro

Abstract excerpt

INTRODUCTION: The genetic background of antidepressant response represents a unique opportunity to identify biological markers of treatment outcome. Encouraging results alternating with inconsistent findings made antidepressant pharmacogenetics a stimulating but often discouraging field that requ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Antidepressive Agents
Share to Genome-Wide Association Study

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Selective Serotonin Reuptake Inhibitors

Share to Treatment Outcome

Source

Identifiers

PMID: 24930681
DOI: 10.1517/17425255.2014.928693

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24930681-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.PMID 24930681Read ↗

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.Semantic proximity Read ↗

Pharmacogenomics of antidepressant drugs.Semantic proximity Read ↗

Progress and prospects in pharmacogenetics of antidepressant drugsSemantic proximity Read ↗

Antidepressant pharmacogeneticsSemantic proximity Read ↗

Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.Semantic proximity Read ↗

Genome-wide association studies in pharmacogenomics of antidepressants.Semantic proximity Read ↗

From Pharmacogenetics to Pharmacogenomics: The Way toward the Personalization of Antidepressant TreatmentSemantic proximity Read ↗

Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directionsSemantic proximity Read ↗

Genetics and personalized medicine in antidepressant treatment.Semantic proximity Read ↗

Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.Semantic proximity Read ↗

Role of pharmacogenomics in individualising treatment with SSRIs.Semantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.